Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-29

FDA Approved: ALBUTEROL — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for albuterol filed by Rising Pharma Holdings, Inc. under ANDA207046.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol (albuterol)

Snippet

ORIG AP for ALBUTEROL (ALBUTEROL)